^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

MIR545 (MicroRNA 545)

i
Other names: MIR545, MicroRNA 545, Hsa-MiR-545-5p, Hsa-MiR-545-3p, Hsa-Mir-545, MIRN545, Hsa-Mir-95-P3-V1_pre, Hsa-Mir-95-P3-V2_pre, MIMAT0004785, MIMAT0003165, MI0003516, Mir-545, RF04053
Associations
Trials
3ms
Identification of Potential Key Ferroptosis-Related Genes in EV71-Infected Cells Through Bioinformatics Analysis and Experimental Study. (PubMed, Curr Microbiol)
In addition, EV71 infection reduces cellular GSH and GPX4 expression, promotes ROS production, and decreases cell viability. These findings reveal significant transcriptional reprogramming of ferroptosis-associated genes during EV71 infection, highlighting a potential role for this pathway that requires direct experimental validation.
Journal
|
IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • STAT3 (Signal Transducer And Activator Of Transcription 3) • FGF2 (Fibroblast Growth Factor 2) • GPX4 (Glutathione Peroxidase 4) • TGFB1 (Transforming Growth Factor Beta 1) • EGR1 (Early Growth Response 1) • MIR20A (MicroRNA 20a) • MIR545 (MicroRNA 545) • TFAP2A (Transcription Factor AP-2 Alpha)
8ms
RETRACTION: MiRNA-545 Negatively Regulates the Oncogenic Activity of EMS1 in Gastric Cancer. (PubMed, Cancer Med)
1 (2024): 155-168, https://doi.org/10.1002/ijc.34677. [4] M. Yang, J. He, S. Xia, Y. Wang, J. Xiong, C. Liao, N. Li, S. Qu, and C. Shen, "Investigation of the Mixed Origins of the MGC-803 Cell Line Reveals That It Is a Hybrid Cell Line Derived from HeLa," Human Cell 37 (2024): 560-566, https://doi.org/10.1007/s13577-023-01011-4.
Journal
|
MIR545 (MicroRNA 545)
8ms
m5C-Modified lncRNA SNHG15 Promotes Ovarian Cancer Progression Via the miR-545-3p/PD-L1 Axis. (PubMed, Reprod Sci)
Furthermore, SNHG15 knockdown impeded tumor growth in mice. In conclusion, m5C-methylated lncRNA SNHG15 promotes OC progression by accelerating cell proliferation and immune evasion via the miR-545-3p/PD-L1 axis, demonstrating a tumor-promoting function of SNHG15 in OC.
Journal • PD(L)-1 Biomarker • IO biomarker
|
CD8 (cluster of differentiation 8) • SNHG5 (Small Nucleolar RNA Host Gene 5) • MIR545 (MicroRNA 545) • SNHG15 (Small Nucleolar RNA Host Gene 15)
10ms
Unraveling the oncogenic role of LINC00504 and its interaction with miR-545-3p and ARIHI in hepatocellular carcinoma: novel insights for molecular therapy. (PubMed, Discov Oncol)
This study uncovers the significant tumor-suppressing role of LINC00504 in HCC, potentially through a mechanism involving the targeting of miR-545-3p, which in turn inhibits the ARIH1. These findings offer new potential targets for HCC molecular treatment.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • CASP3 (Caspase 3) • MIR545 (MicroRNA 545)
10ms
The emerging roles and mechanisms of FAM83H‑AS1 in cancer: Pathophysiology and therapeutic implications (Review). (PubMed, Oncol Lett)
FAM83H-AS1 may be a promising biomarker for cancer diagnosis and prognosis. The present review summarises the expression, mechanism and potential clinical application of FAM83H-AS1 in cancer diagnosis and prognosis.
Review • Journal
|
CTNNB1 (Catenin (cadherin-associated protein), beta 1) • MIR15A (MicroRNA 15a) • MIR545 (MicroRNA 545)
over1year
The LINC01094/miR-545-3p/SLC7A11 Signaling Axis Promotes the Development of Gastric Cancer by Regulating Cell Growth and Ferroptosis. (PubMed, Biochem Genet)
These findings indicate that miR-545-3p could target and positively correlate with SLC7A11 expression. Additionally, LINC01094 could promote GC cell progression and affect cellular ferroptosis by regulating the miR-545-3p/SLC7A11 signaling axis.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • CCND1 (Cyclin D1) • CASP3 (Caspase 3) • SLC7A11 (Solute Carrier Family 7 Member 11) • CDKN1A (Cyclin-dependent kinase inhibitor 1A) • LINC01094 (Long Intergenic Non-Protein Coding RNA 1094) • MIR545 (MicroRNA 545)
|
BCL2 expression • CCND1 expression • SLC7A11 expression
over1year
LncRNA LINC00261 associates with chemoresistance and clinical prognosis in patients with epithelial ovarian cancer. (PubMed, J Obstet Gynaecol Res)
This research indicates that the aberrant hypermethylation and low expression of LINC00261 were associated with platinum resistance and adverse outcomes in EOC patients.
Journal
|
MIR545 (MicroRNA 545) • MT1M (Metallothionein 1M)
|
cisplatin
over1year
Current and future perspectives on the regulation and functions of miR-545 in cancer development. (PubMed, Cancer Pathog Ther)
In summary, miR-545 holds immense potential as a cancer biomarker and therapeutic target. The aberrant expression and regulatory mechanisms of miR-545 in cancer warrant further investigation.
Review • Journal • IO biomarker
|
HAVCR2 (Hepatitis A Virus Cellular Receptor 2) • MIR545 (MicroRNA 545)
over1year
Circ_0081723 enhances cervical cancer progression and modulates CREBRF via sponging miR-545-3p. (PubMed, Naunyn Schmiedebergs Arch Pharmacol)
Circ_0081723 silencing suppressed CC cell growth and motility whereas boosted CC cell apoptosis. Besides, circ_0081723 acted as a molecular sponge for miR-545-3p, and circ_0081723 knockdown-induced effects were largely reversed by miR-545-3p downregulation in CC cells. Moreover, miR-545-3p repressed CC progression by targeting CREBRF.  Circ_0081723 absence blocked xenograft tumor growth in vivo. Circ_0081723 stimulated CC cell malignant behaviors by regulating the miR-545-3p/CREBRF pathway, providing a possible circRNA-targeted therapy for CC.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • CDH1 (Cadherin 1) • CREBRF (CREB3 Regulatory Factor) • MIR545 (MicroRNA 545)
almost2years
Downregulation of circ-RAPGEF5 inhibits colorectal cancer progression by reducing the expression of polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3). (PubMed, Environ Toxicol)
These findings revealed that circ-RAPGEF5 played an oncogenic role through the miR-545-5p/GALNT3 axis in CRC progression, providing potential therapeutic targets for the treatment of CRC.
Journal
|
MIR545 (MicroRNA 545)
almost2years
LncRNA PCAT6 mediates UBFD1 expression via sponging miR-545-3p in breast cancer cells. (PubMed, Noncoding RNA Res)
Our study provided evidence that PCAT6 activates UBFD1 expression via sponging miR-545-3p to increase carcinogenesis of breast cancer cells. Based on the nature of UBFD1 as a polyubiquitin binding protein, our study suggested that ubiquitin pathway might contribute to breast cancer progression.
Journal
|
MIR545 (MicroRNA 545) • PCAT6 (Prostate Cancer Associated Transcript 6)